Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prehabilitation in Patients With Multiple Myeloma Receiving CAR-T Therapy

NCT07045727 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07045727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07045727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prehabilitation in Patients With Multiple Myeloma Receiving CAR-T Therapy
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
August 18, 2025
Completion date
June 16, 2026
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent multiple myeloma, refractory multiple myeloma